Explore more publications!

Mauritius Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mauritius Healthcare Daily.

Press releases published on March 2, 2026

Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026
Boomer Benefits Celebrates Over 13,000 5-Star Reviews, Reinforcing Its Aim to Become the Best Medicare Broker in Dallas, Texas
OSE Immunotherapeutics Accelerates Strategic Refocusing to Advance Late Stage Value Drivers Lusvertikimab and Tedopi®
OSE Immunotherapeutics accélère son recentrage stratégique autour de ses principaux leviers de création de valeur en phase avancée: Lusvertikimab et Tedopi®
Pediatric Home Service Partners with Morgan’s to Expand Prescribed Pediatric Extended Care Services in Texas with New Center, Morgan’s Wonder Care
Valneva annonce sa participation à des conférences investisseurs
Valneva to Participate in Upcoming Investor Conferences
ROOT Brands CEO and Architect Clayton Thomas Joins Dr. Christina Rahm to Launch Global Philanthropic Alliance with The Clydeo Fund
PACHA Debuts Improved Organic Sourdough Buckwheat Tortillas at Expo West, Signals Next Phase of Growth
Living with a Rare Disease: A Pastor’s Journey Finding the Right Care and Treatment for NF1-PN 
Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform
Don’t Kidney Around This National Kidney Month, Get the Facts Your Kidneys Wish You Knew
Academy of Nutrition and Dietetics Celebrates Power of Nutrition for 2026 National Nutrition Month®
Health-ISAC Releases Its 2025 Annual Report
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
American Kidney Fund Brings Kidney Community Together March 2-5 for Seventh Annual Kidney Action Week
Interra Health, created through the merger of DoseSpot and Arrive Health, ushers in a new era of transparency for patients and providers
SAB BIO to Participate in Upcoming Investor Conferences
AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer
Palisade Bio Announces Participation in Two Upcoming Investor Conferences

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions